Loading...
Eye on the Ball: Medicine regulation - not IP enforcement - can best deliver quality medicine
Brant, Jennifer Malpani, Rohit
Brant, Jennifer
Malpani, Rohit
Citations
Altmetric:
Titre
Publication date
2011-02-02
Document type
Briefing paper
Pages
51
Author(s)
Advisors
Editor(s)
Other Contributors
Affiliation
ePub Date
Submitted date
Subject
Local subject classification
MeSH
Keywords
Country
Collections
Files
Loading...
English paper
Adobe PDF, 501.39 KB
Loading...
English summary
Adobe PDF, 118.36 KB
Loading...
French paper
Adobe PDF, 496.99 KB
Loading...
French summary
Adobe PDF, 116.38 KB
Loading...
Spanish paper
Adobe PDF, 472.88 KB
Description
Poor-quality medicines pose a serious threat to patients and public health in developing countries. The World Health Organisation estimates nearly one-third of all countries lack adequate drug-regulatory capacity to monitor medicines safety.
Under the guise of addressing this problem, some rich countries are pushing for new intellectual-property rules and a reliance on police action to keep substandard medicines out of reach. Such an approach will not ensure consistent medicine quality. Worse, it threatens to undermine access to legitimate, affordable generic medicines.
Donors and developing countries must prioritize building competent regulatory authorities - not expand intellectual-property enforcement - so that patients can be assured that the medicines they take are safe and effective.
Language
English
French
Spanish
French
Spanish